Skip to main content
48°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
DBV Technologies S.A. - American Depositary Shares
(NQ:
DBVT
)
9.340
-0.500 (-5.08%)
Streaming Delayed Price
Updated: 2:46 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DBV Technologies S.A. - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
March 08, 2024
From
DBV Technologies S.A.
Via
GlobeNewswire
DBVT Stock Earnings: DBV Technologies Beats EPS, Beats Revenue for Q4 2023
March 07, 2024
DBVT stock results show that DBV Technologies beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
March 07, 2024
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
March 04, 2024
From
DBV Technologies S.A.
Via
GlobeNewswire
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
A Preview Of DBV Technologies's Earnings
March 06, 2024
Via
Benzinga
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
February 20, 2024
From
DBV Technologies S.A.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 20, 2024
Via
Benzinga
DBV Technologies And 2 Other Stocks Under $2 Insiders Are Buying
February 09, 2024
The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
January 16, 2024
From
DBV Technologies S.A.
Via
GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023
December 04, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Top 5 Health Care Stocks That Could Blast Off In December
December 01, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
November 09, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
November 06, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Present New Data at ACAAI 2023
November 02, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
November 01, 2023
Gainers
Via
Benzinga
DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
October 31, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
October 27, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
October 16, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
October 05, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conference
September 05, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
August 29, 2023
The Dow Jones closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying
August 04, 2023
The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 02, 2023
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.
Via
Benzinga
Cambium Networks, SolarEdge Technologies, trivago And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
August 02, 2023
U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
DBV Technologies Advances Peanut Allergy Program With FDA Support On Pediatric Studies
August 01, 2023
DBV Technologies (NASDAQ: DBVT) received Type C meeting written responses from the FDA on key study design elements for the COMFORT Toddlers and COMFORT Children supplemental safety studies in 1 –...
Via
Benzinga
DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
July 31, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
July 25, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
July 19, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.